Off Patent
March 2026

Naproxen Sodium

naproxen sodium

Bionpharma Inc

Capsule (oral) · NDA 021920

Last listed protection ended
March 3, 2026

The FDA listed 5 patents for Naproxen Sodium, and this is the day the last one ended. It is not the date a generic goes on sale.

Patents and exclusivities

  1. Ended
    Patent 9,693,978
    Claims the drug product
  2. Ended
    Patent 9,693,979
    Claims the drug product
  3. Ended
    Patent 10,022,344
    Claims the drug product and a use (U-1731, U-1732)
  4. Ended
    Patent 10,028,925
    Claims the drug product and a use (U-1731, U-1732)
  5. Ended
    Patent 11,090,280
    Claims the drug product and a use (U-1731, U-1732)